Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10

J Antibiot (Tokyo). 2013 Oct;66(10):625-7. doi: 10.1038/ja.2013.56. Epub 2013 May 29.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology*
  • Drug Resistance, Multiple, Bacterial*
  • Enterobacteriaceae / classification
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / isolation & purification
  • Enterobacteriaceae Infections / microbiology
  • Enterococcus / drug effects*
  • Enterococcus / isolation & purification
  • Fosfomycin / pharmacology*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Michigan
  • Microbial Sensitivity Tests
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology
  • Vancomycin Resistance*
  • beta-Lactam Resistance

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Fosfomycin